MetLife Q3 2026 Results: Net Income $2.35 Billion on Revenue of $20.52 Billion
- US stocks
- Earnings
- Financials
MetLife (NYSE: MET) reported GAAP revenue of $20.5 billion and GAAP net income of $2.35 billion available to common shareholders for the third quarter of 2026, it said on 4 Nov 2026. Diluted EPS was $3.67 on a GAAP basis, and adjusted earnings per share, a company-defined measure, was $2.78, or $2.85 excluding total notable items.
Key highlights
- Revenue (GAAP): $20.5 billion, up 18.2% YoY
- Net income available to common shareholders (GAAP): $2.35 billion, up 187.4% YoY
- Diluted EPS (GAAP): $3.67, up 200.8% YoY
- Net income margin (GAAP): 11.5% of revenue, against 4.7% a year earlier
- Adjusted earnings per share (company-defined): $2.78
Summary
| Particulars | Q3 2026 | Q3 2025 | YoY |
|---|---|---|---|
| Revenue | 20,522.0 | 17,361.0 | +18.2% |
| 2,351.0 | 818.0 | +187.4% | |
| Net income margin | 11.46% | 4.71% | +6.75 pp |
| Diluted EPS ($) | 3.67 | 1.22 | +200.8% |
Figures are in $ million except EPS; YoY compares with Q3 2025. Q3 2026 is the three months to 30 Sep 2026, from the company's release. Earlier quarters are the release's own comparatives, not cross-checked against SEC XBRL data. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.
The table sets third-quarter 2026 GAAP figures against the same quarter of 2025, using the figures in the release. Revenue rose 18.2% from a year earlier, to $20.5 billion from $17.4 billion. Net income rose 187.4%, to $2.35 billion from $818.0 million, and diluted EPS rose 200.8%, to $3.67 from $1.22.
The net income margin was 11.5% of revenue, against 4.7% a year earlier. The year-ago figures in the table are the comparatives printed in the release.
Adjusted earnings rose 12% on a reported basis
Adjusted earnings, a non-GAAP measure, were $1.8 billion, up 12% on a reported basis and 13% on a constant currency basis. Excluding total notable items, adjusted earnings were $1.83 billion. The company's adjusted earnings leave out market-driven items, including net investment gains and losses, net derivative gains and losses, and market risk benefit remeasurement gains and losses.
The company attributes the higher adjusted earnings to higher variable investment income, broad-based volume growth and favorable underwriting. The company also linked its annual actuarial assumption review to a $56 million cut in net income and a $46 million cut in adjusted earnings.
The company said net derivative gains of $551 million after tax came from gains on embedded derivatives tied to ceded reinsurance, which it linked to higher U.S. interest rates.
RIS adjusted earnings fell 6% while Latin America rose 45%
Retirement and Income Solutions (RIS) adjusted earnings were $413 million, down 6%. The company said this reflected notable items from the annual actuarial assumption review. Excluding notable items, RIS adjusted earnings rose 12% to $478 million.
Latin America adjusted earnings were $215 million, up 45% on a reported basis and up 30% on a constant currency basis. The company said the increase reflected the annual actuarial review and a value-added tax charge in Mexico in the prior-year period.
Group Benefits adjusted earnings were $523 million, up 15%. Excluding notable items, they rose 14%, which the company said mainly reflected favorable underwriting.
Free cash flow and expense targets are on track
The release gives no numeric 2026 outlook. The company said it is on track to deliver against its free cash flow ratio and direct expense ratio targets for the year.
Inference
Weighted average diluted common shares were 639.9 million in the quarter, against 669.1 million a year earlier, and common shares outstanding were 631.1 million at 30 Sep 2026. The company said it made share repurchases of $650 million in the quarter, paid $380 million of common stock dividends, and made a further $265 million of repurchases in October 2026.
Filed with the US SEC on . Reference: Original filing (SEC)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

